Health portal startup Navigating Cancer has raised another $10 million as the Seattle company continues to grow and offer more tools to help cancer patients engage with doctors and track their treatment.
A company spokesperson tells me they’re working to position themselves to ride the wave as the U.S. healthcare system shifts toward value-based medicine, an industry buzzword that means hospitals are doing more now track the direct results of their care.
With new federal mandates requiring technology-based solutions to engage with patients, we’re going to see more and more hospitals out shopping for software options. And that’s a big opportunity for companies like Navigating Cancer.
“This shift makes patient engagement more important than ever, and Navigating Cancer has been dedicated to building technology to boost patient engagement since 2008,” senior marketing director Eileen Faucher wrote in an email. “The team here has a deep understanding of what oncology clinics need today to stay ahead of the curve.”
Navigating Cancer’s platform is used by over 1,300 healthcare professionals, and more than 1 million patients. The company recently launched its first mobile app, which sends reminders for things like taking pills and keeps doctors in the loop on how patients are feeling.
The the money, the company plans to roughly double from 30 employees to 60. It’s also working to expand its Seattle office space.
The $10 million funding round was led by Merck Global Health Innovation Fund, ORIX Healthcare Capital and existing investor Rustic Canyon Partners. The company has now raised a total of $15 million.